Israel: Redhill Bio places US$6m convertible promissory note with one investor

Redhill Biopharma, a specialty biopharmaceutical company, has placed a US$6m convertible promissory note (convertible into ADS) and warrants with a single investor. Advances under the promissory note are to be made in three tranches of US$2m, US$1m, and US$3m respectively. The first tranche will be paid upon closing, and the second and third tranches will be advanced following…